Generic drugs in ophthalmic practice: Boon or bane?

Generic pharma products are inexpensive as compared to the original innovator branded drugs. True generics are not freely available in India. There have been concerns about efficacy and quality of generics that are available. This review outlines these issues and the legislation regarding the availa...

Full description

Bibliographic Details
Main Authors: Murali Ariga, M Rajalakshmi, C Praveena
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:TNOA Journal of Ophthalmic Science and Research
Subjects:
Online Access:http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2017;volume=55;issue=3;spage=220;epage=222;aulast=Ariga
_version_ 1818502309443796992
author Murali Ariga
M Rajalakshmi
C Praveena
author_facet Murali Ariga
M Rajalakshmi
C Praveena
author_sort Murali Ariga
collection DOAJ
description Generic pharma products are inexpensive as compared to the original innovator branded drugs. True generics are not freely available in India. There have been concerns about efficacy and quality of generics that are available. This review outlines these issues and the legislation regarding the availability and use of generics in our practice.
first_indexed 2024-12-10T21:08:32Z
format Article
id doaj.art-c8d71041432e4e0a9f70cbc143672439
institution Directory Open Access Journal
issn 2589-4528
2589-4536
language English
last_indexed 2024-12-10T21:08:32Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series TNOA Journal of Ophthalmic Science and Research
spelling doaj.art-c8d71041432e4e0a9f70cbc1436724392022-12-22T01:33:33ZengWolters Kluwer Medknow PublicationsTNOA Journal of Ophthalmic Science and Research2589-45282589-45362017-01-0155322022210.4103/tjosr.tjosr_34_17Generic drugs in ophthalmic practice: Boon or bane?Murali ArigaM RajalakshmiC PraveenaGeneric pharma products are inexpensive as compared to the original innovator branded drugs. True generics are not freely available in India. There have been concerns about efficacy and quality of generics that are available. This review outlines these issues and the legislation regarding the availability and use of generics in our practice.http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2017;volume=55;issue=3;spage=220;epage=222;aulast=Arigagenericsbranded genericsinnovator brandsefficacycost effectiveness
spellingShingle Murali Ariga
M Rajalakshmi
C Praveena
Generic drugs in ophthalmic practice: Boon or bane?
TNOA Journal of Ophthalmic Science and Research
generics
branded generics
innovator brands
efficacy
cost effectiveness
title Generic drugs in ophthalmic practice: Boon or bane?
title_full Generic drugs in ophthalmic practice: Boon or bane?
title_fullStr Generic drugs in ophthalmic practice: Boon or bane?
title_full_unstemmed Generic drugs in ophthalmic practice: Boon or bane?
title_short Generic drugs in ophthalmic practice: Boon or bane?
title_sort generic drugs in ophthalmic practice boon or bane
topic generics
branded generics
innovator brands
efficacy
cost effectiveness
url http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2017;volume=55;issue=3;spage=220;epage=222;aulast=Ariga
work_keys_str_mv AT muraliariga genericdrugsinophthalmicpracticeboonorbane
AT mrajalakshmi genericdrugsinophthalmicpracticeboonorbane
AT cpraveena genericdrugsinophthalmicpracticeboonorbane